These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7939751)
21. [Prostatic carcinoma: current status of diagnostic imaging]. Bloch BN; Helbich T; Heinz-Peer G Wien Med Wochenschr Suppl; 2002; (113):89-91. PubMed ID: 12621851 [TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies: the promise and the reality. Coons T Radiol Technol; 1995; 67(1):39-60; quiz 61-4. PubMed ID: 7491408 [TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies in the diagnosis and treatment of the colorectal cancer. Dziki A Acta Chir Iugosl; 1998; 45(2 Suppl):35-6. PubMed ID: 10951784 [No Abstract] [Full Text] [Related]
24. The current status of radiolabeled monoclonal antibodies for the diagnosis and treatment of human malignancies. Kuzel TM; Duda RB Compr Ther; 1992 Jun; 18(6):16-20. PubMed ID: 1511591 [No Abstract] [Full Text] [Related]
25. Monoclonal antibodies used in the detection and treatment of epithelial ovarian cancer. Muto MG; Kassis AI Cancer; 1995 Nov; 76(10 Suppl):2016-27. PubMed ID: 8634994 [TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer. Abdel-Nabi H; Wright GL; Gulfo JV; Petrylak DP; Neal CE; Texter JE; Begun FP; Tyson I; Heal A; Mitchell E Semin Urol; 1992 Feb; 10(1):45-54. PubMed ID: 1565904 [No Abstract] [Full Text] [Related]
27. New developments in monoclonal antibodies for cancer detection and therapy. Goldenberg DM CA Cancer J Clin; 1994; 44(1):43-64. PubMed ID: 8281471 [TBL] [Abstract][Full Text] [Related]
28. [Cancer of the prostate. Present status of diagnosis, prognosis and therapy]. Bouffioux Acta Urol Belg; 1975 Oct; 43(4):352-75. PubMed ID: 1231536 [No Abstract] [Full Text] [Related]
29. The role of PAM4 in the management of pancreatic cancer: diagnosis, radioimmunodetection, and radioimmunotherapy. Han S; Jin G; Wang L; Li M; He C; Guo X; Zhu Q J Immunol Res; 2014; 2014():268479. PubMed ID: 24818166 [TBL] [Abstract][Full Text] [Related]
30. [Recommendations for the diagnosis and therapy of prostate cancer]. Rockstroh H Z Urol Nephrol; 1979 Jul; 72(12):515-6. PubMed ID: 525072 [No Abstract] [Full Text] [Related]
31. Monoclonal antibodies in cancer detection and therapy. Goldenberg DM Am J Med; 1993 Mar; 94(3):297-312. PubMed ID: 8452154 [TBL] [Abstract][Full Text] [Related]
33. 3rd Scandinavian Symposium on Radiolabeled Monoclonal Antibodies for Cancer Diagnosis and Therapy. Proceedings. Helsinki, Finland, October 30-31, 1992. Acta Oncol; 1993; 32(7-8):707-891. PubMed ID: 7905745 [No Abstract] [Full Text] [Related]
34. Current status of tumor imaging with monoclonal antibodies. Blend MJ Compr Ther; 1991 Dec; 17(12):5-11. PubMed ID: 1790666 [TBL] [Abstract][Full Text] [Related]
35. 4th Scandinavian Symposium on Radiolabeled Monoclonal Antibodies in Diagnosis and Therapy of Cancer. Lillehammer, Norway, January 15-17, 1995. Acta Oncol; 1996; 35(3):257-390. PubMed ID: 8679253 [No Abstract] [Full Text] [Related]
36. Pretargeted peptide imaging and therapy. Goodwin DA; Meares CF Cancer Biother Radiopharm; 1999 Jun; 14(3):145-52. PubMed ID: 10850299 [No Abstract] [Full Text] [Related]
37. How far should we investigate and treat prostate cancer? Sladden MJ; Dickinson JA; Thomson A Med J Aust; 1994 Dec 5-19; 161(11-12):722. PubMed ID: 7695746 [No Abstract] [Full Text] [Related]